Home GU Oncology Now GU Precision Medicine in Prostate Cancer

GU Precision Medicine in Prostate Cancer

Studies Reveal Aggressive Prostate Cancer Linked to Ancestral Heritage

Risk of Prostate Cancer Death After Benign TURP, Low PSA Levels Very Low

Nitric Oxide Exposure Induces Prostate Cancer Carcinogenesis and Pro-Tumor Phenotype

Can Drinking Coffee Benefit Prostate Cancer Patients with a Certain Genotype?

A Small Peptide that Inhibits the Invasive Phenotype in Prostate Cancer

Assessing Genomic Biomarkers to Enhance Precision Medicine in Prostate Cancer

FDA Approves Darolutamide, Docetaxel Combination for Metastatic Hormone-Sensitive Prostate Cancer

Certain Risk Factors Could Prevent Unnecessary Biopsy in PI-RADS 3 Lesions

Analyzing Cystography Parameters to Predict Urinary Continence Recovery Following Prostate Cancer Surgery

Assessing the Link Between Autophagy-Related Genes and Prostate Cancer Progression

Load more
Subscribe to RSS